[Incidence and associated factors of anemia within six months after kidney transplantation in pediatric recipients].

Q3 Medicine
北京大学学报(医学版) Pub Date : 2026-08-18
Wenlin Li, Lei Yu, Wenbo Yang, Jiankang Dong, Yujie Yang, Zhao Zhao, Jianfei Wang, Weiyu Zhang, Qiang Wang
{"title":"[Incidence and associated factors of anemia within six months after kidney transplantation in pediatric recipients].","authors":"Wenlin Li, Lei Yu, Wenbo Yang, Jiankang Dong, Yujie Yang, Zhao Zhao, Jianfei Wang, Weiyu Zhang, Qiang Wang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Anemia is a common complication following kidney transplantation in children, yet its epidemiological characteristics and associated factors are not fully understood. This study aimed to investigate the incidence and clinical features of anemia within six months after pediatric kidney transplantation and to identify its associated factors, thereby providing evidence for management.</p><p><strong>Methods: </strong>A single-center retrospective cohort study was conducted on pediatric patients who underwent kidney transplantation at Peking University People' s Hospital from January 2022 to August 2025. Demographic, perioperative, and serial laboratory data up to 6 months post-transplantation were collected. Anemia was diagnosed according to the World Health Organization (WHO) age-specific criteria. Univariate analysis, multivariate binary Logistic regression, and receiver operating characteristic (ROC) curve analysis were performed to identify associated factors and assess their diagnostic value.</p><p><strong>Results: </strong>The study included 46 pediatric recipients. The incidence of anemia within 6 months post-transplantation was 41.3% (19/46), with normocytic anemia being the most prevalent type (63.1%, 12/19). Multivariate binary Logistic regression analysis showed that age (<i>OR</i>=0.293, <i>P</i>=0.018), postoperative serum urea at 6 months (<i>OR</i>=3.281, <i>P</i>=0.006), and estimated glomerular filtration rate (eGFR) (<i>OR</i>=0.893, <i>P</i>=0.030) were independently associated with anemia. Exploratory stratified analysis suggested that age < 13 years, serum urea >7 mmol/L, and eGFR < 120 mL/(min·1.73 m<sup>2</sup>) might serve as reference thresholds for clinical screening. ROC curve analysis indicated that postoperative serum urea had the best diagnostic value for anemia (area under the curve=0.890, <i>P</i> < 0.001). Hemoglobin levels began to differ significantly between the anemic and non-anemic groups from the third month postoperative onward, with the gap widening over time.</p><p><strong>Conclusion: </strong>This study demonstrates a high incidence of early-onset anemia after pediatric kidney transplantation, primarily mild to moderate normocytic anemia. It is associated with younger age and suboptimal allograft function, with the divergence in hemoglobin levels becoming apparent from the third month postoperative. Close monitoring of high-risk children, particularly those aged < 13 years or with serum urea >7 mmol/L and eGFR < 120 mL/(min·1.73 m<sup>2</sup>), and early intervention may help reduce the occurrence or severity of post-transplant anemia.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"58 4","pages":"729-737"},"PeriodicalIF":0.0000,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13402052/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Anemia is a common complication following kidney transplantation in children, yet its epidemiological characteristics and associated factors are not fully understood. This study aimed to investigate the incidence and clinical features of anemia within six months after pediatric kidney transplantation and to identify its associated factors, thereby providing evidence for management.

Methods: A single-center retrospective cohort study was conducted on pediatric patients who underwent kidney transplantation at Peking University People' s Hospital from January 2022 to August 2025. Demographic, perioperative, and serial laboratory data up to 6 months post-transplantation were collected. Anemia was diagnosed according to the World Health Organization (WHO) age-specific criteria. Univariate analysis, multivariate binary Logistic regression, and receiver operating characteristic (ROC) curve analysis were performed to identify associated factors and assess their diagnostic value.

Results: The study included 46 pediatric recipients. The incidence of anemia within 6 months post-transplantation was 41.3% (19/46), with normocytic anemia being the most prevalent type (63.1%, 12/19). Multivariate binary Logistic regression analysis showed that age (OR=0.293, P=0.018), postoperative serum urea at 6 months (OR=3.281, P=0.006), and estimated glomerular filtration rate (eGFR) (OR=0.893, P=0.030) were independently associated with anemia. Exploratory stratified analysis suggested that age < 13 years, serum urea >7 mmol/L, and eGFR < 120 mL/(min·1.73 m2) might serve as reference thresholds for clinical screening. ROC curve analysis indicated that postoperative serum urea had the best diagnostic value for anemia (area under the curve=0.890, P < 0.001). Hemoglobin levels began to differ significantly between the anemic and non-anemic groups from the third month postoperative onward, with the gap widening over time.

Conclusion: This study demonstrates a high incidence of early-onset anemia after pediatric kidney transplantation, primarily mild to moderate normocytic anemia. It is associated with younger age and suboptimal allograft function, with the divergence in hemoglobin levels becoming apparent from the third month postoperative. Close monitoring of high-risk children, particularly those aged < 13 years or with serum urea >7 mmol/L and eGFR < 120 mL/(min·1.73 m2), and early intervention may help reduce the occurrence or severity of post-transplant anemia.

[儿童肾移植后6个月内贫血的发生率及相关因素]。
目的:贫血是儿童肾移植术后常见的并发症,但其流行病学特征及相关因素尚不完全清楚。本研究旨在探讨小儿肾移植术后6个月内贫血的发生率及临床特点,并探讨其相关因素,为治疗提供依据。方法:对2022年1月至2025年8月北京大学人民医院肾移植患儿进行单中心回顾性队列研究。收集了移植后6个月的人口学、围手术期和一系列实验室数据。贫血是根据世界卫生组织(世卫组织)的年龄特定标准诊断的。采用单因素分析、多因素二元Logistic回归和受试者工作特征(ROC)曲线分析,确定相关因素并评估其诊断价值。结果:该研究包括46名儿科受体。移植后6个月内的贫血发生率为41.3%(19/46),其中最常见的贫血类型为正红细胞贫血(63.1%,12/19)。多因素Logistic回归分析显示,年龄(OR=0.293, P=0.018)、术后6个月血清尿素(OR=3.281, P=0.006)、肾小球滤过率(eGFR)估计值(OR=0.893, P=0.030)与贫血独立相关。探索性分层分析提示,年龄< 13岁、血清尿素bbb7 mmol/L、eGFR < 120 mL/(min·1.73 m2)可作为临床筛查的参考阈值。ROC曲线分析显示,术后血清尿素对贫血的诊断价值最高(曲线下面积=0.890,P < 0.001)。从术后第三个月开始,贫血组和非贫血组之间的血红蛋白水平开始出现显著差异,随着时间的推移,差距越来越大。结论:本研究表明儿童肾移植术后早发性贫血发生率高,主要为轻至中度正红细胞性贫血。它与年龄较小和异体移植物功能不佳有关,从术后第三个月开始,血红蛋白水平的差异变得明显。密切监测高危儿童,特别是年龄< 13岁或血清尿素bbb7 mmol/L、eGFR < 120 mL/(min·1.73 m2)的高危儿童,并进行早期干预可能有助于减少移植后贫血的发生或严重程度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍: Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases. The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书